Search
for
Sort by
Research 871–900 of 1000+
- Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Detecting shortcut learning for fair medical AI using shortcut testing
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- Knockout of integrin β1 in induced pluripotent stem cells accelerates skin-wound healing by promoting cell migration in extracellular matrix
- Methotrexate Effectively Controls Ocular Inflammation in Japanese Patients With Non-infectious Uveitis
- Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- The level of stress and the assessment of selected clinical parameters in patients with androgenetic alopecia.
- Manifestaciones clínicas y complicaciones de la enfermedad por coronavirus 2019 (COVID-19): revisión de la literatura
- Balint’s syndrome—missed or mistaken?
- Molecular Engineering of Recombinant Protein Hydrogels: Programmable Design and Biomedical Applications
- Superfoods: exploring sustainability perspectives between nutrient synthesizers and accumulators
- Antibacterial potential and phytochemical analysis of two ethnomedicinally important plants
- Antibacterial Potency of an Active Compound from Sansevieria trifasciata Prain: An Integrated In Vitro and In Silico Study
- Bionanomaterials: Advancements in Wound Healing and Tissue Regeneration
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- The Role of the Microbiome in the Resolution of Infection-Induced Inflammation
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Ensuring safety in cytotoxic drug preparation: A systematic review of guidelines addressing education for pharmacy professionals
- Chitosan Nanoparticle-Encapsulated Cordyceps militaris Grown on Germinated Rhynchosia nulubilis Reduces Type II Alveolar Epithelial Cell Apoptosis in PM2.5-Induced Lung Injury
- A window into the vascular endothelium in COVID-19: Nails
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Associations between sugar-sweetened beverages consumption, duration of physical exercise, and depressive symptoms among Tibetan university students at high altitude